Genmab's Tivdak wins Japan's approval for advanced cervical cancer after a Phase 3 trial showed improved survival over chemotherapy.

One woman's story of literal strength illustrates how ovarian cancer symptoms can be missed—and the lighthearted recovery ...

A consultant gynaecologist who recommended Ann Summers products to an elderly patient with vaginal bleeding, but who failed ...

Genmab (GMAB) announced that the Japan Ministry of Health, Labour and Welfare has approved Tivdak for the treatment of advanced or recurrent ...

From X-ray and cancer screening to embryology and beyond, the medical world is using AI to develop new treatments, though ...

Omni Family Health Omni Family Health is raising awareness about cervical cancer and the importance of early detection ...

Evolution in women's cancer diagnostics: from histopathology to molecular testing, personalized treatment for breast, ovarian ...

Breaking news. Lovemore Kadzura THOUSANDS of villagers in Makoni West Constituency have benefited from a free cancer ...

Of 8,000 women who underwent cervical cancer screening in recent months, reports of 450 came positive, who need further ...

Satya Kumar says following Anaparthy MLA’s concerns in Assembly and media reports, 31 teams from consisting of health ...

The HPV vaccine, called Gardasil-9 — which has no live virus and is completely non-infectious — protects against the six types of HPV most likely to cause cancer, Eckert says. (These are strains 6, 11 ...

The addition of pembrolizumab to chemoradiotherapy improved survival outcomes for women with high-risk, locally advanced ...